Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net loss $ (747,943) $ (1,149,651)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 70,683 2,259
Amortization of intangibles   9,486
Stock-based compensation 500,718 367,600
Loss on settlement of accounts payable  
Bad debt expense (15,000)  
Gain (loss) on change in fair value of warrant assets  
Settlement of disputed contractual claim
Issuance of warrants in settlement of lease dispute
Common stock issued in settlement of litigation  
Gain on exchange of debt for common stock  
Issuance of common stock in settlement of Series A Convertible Preferred Stock contractual fee  
Gain (loss) on change in fair value of convertible notes receivable  
Non cash interest income  
Non cash interest expense  
Other income  
Changes in operating assets and liabilities:    
Accounts receivable (285,030) 193,031
Prepaid expenses and other assets (37,382) (349,434)
Other assets
Accounts payable and accrued liabilities 148,553 305,848
Deferred revenue (61,500) 334,000
Net cash used in operating activities (426,901) (286,861)
Cash flows from investing activities:
Cash flows from financing activities:    
Proceeds from notes payable 139,595  
Net cash provided by financing activities 139,595  
Net (decrease) increase in cash (287,306) (286,861)
Cash, beginning of period 376,425 487,953
Cash, end of period 89,119 201,092
Supplemental disclosures of cash flow information:    
Cash paid for interest
Cash paid for income taxes
Non-cash investing and financing activities:    
Shares issued for equity financing 250,000
Shares issued for vested restricted stock units 9
Shares issued to a current and former employee $ 67